Literature DB >> 31217018

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.

Yu Yin1,2,3, Lingfan Xu1,2, Yan Chang2,4, Tao Zeng2,5, Xufeng Chen2, Aifen Wang2, Jeff Groth2, Wen-Chi Foo2, Chaozhao Liang6, Hailiang Hu7,8, Jiaoti Huang9,10,11.   

Abstract

Following publication of the original article [1], the authors reported that name that appeared in published online version is incorrect. Aifeng Wang should be Aifen Wang. Corrected name is provided in the author group section above.

Entities:  

Year:  2019        PMID: 31217018      PMCID: PMC6582568          DOI: 10.1186/s12943-019-1034-y

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


Correction to: Mol Cancer https://doi.org/10.1186/s12943-019-0941-2 Following publication of the original article [1], the authors reported that name that appeared in published online version is incorrect. Aifeng Wang should be Aifen Wang. Corrected name is provided in the author group section above.
  1 in total

1.  N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Authors:  Yu Yin; Lingfan Xu; Yan Chang; Tao Zeng; Xufeng Chen; Aifeng Wang; Jeff Groth; Wen-Chi Foo; Chaozhao Liang; Hailiang Hu; Jiaoti Huang
Journal:  Mol Cancer       Date:  2019-01-18       Impact factor: 27.401

  1 in total
  2 in total

1.  A potential new role of ATM inhibitor in radiotherapy: suppressing ionizing Radiation-Activated EGFR.

Authors:  Siyuan Tang; Zhentian Li; Lifang Yang; Liangfang Shen; Ya Wang
Journal:  Int J Radiat Biol       Date:  2020-01-08       Impact factor: 2.694

Review 2.  Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer.

Authors:  Marzieh Ehsani; Faith Oluwakemi David; Aria Baniahmad
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.